TB Research

Prevalence of Advanced HIV Disease, Cryptococcal Antigenemia, and Suboptimal Clinical Outcomes Among Those Enrolled in Care in Vietnam

Dat VQ, Lyss S, Dung NTH, Hung LM, Pals SL, Anh HTV, Kinh NV, Bateganya M

Journal of acquired immune deficiency syndromes (1999) · 2021-12

Abstract

Background People living with advanced HIV disease are at high risk of morbidity and mortality. We assessed the prevalence of cryptococcal antigenemia (CrAg) and clinical outcomes among patients newly presenting with CD4 ≤100 cells/μL in Vietnam. Setting Twenty-two public HIV clinics in Vietnam. Methods During August 2015-March 2017, antiretroviral therapy (ART)-naïve adults presenting for care with CD4 ≤100 cells/μL were screened for CrAg. Those who consented to study enrollment were followed up for up to 12 months and assessed for clinical outcomes. Results Of 3504 patients with CD4 results, 1354 (38.6%) had CD4 ≤100 cells/μL, of whom 1177 (86.9%) enrolled in the study. The median age was 35 years (interquartile range 30-40); 872 (74.1%) of them were men, and 892 (75.8%) had CD4 Conclusions Late presentation for HIV care was common. The high mortality after entry in care calls for strengthening of the management of advanced HIV disease.

MeSH terms

  • CD4-Positive T-Lymphocytes
  • Humans
  • Cryptococcus
  • AIDS-Related Opportunistic Infections
  • Cryptococcosis
  • HIV Infections
  • Antigens, Fungal
  • CD4 Lymphocyte Count
  • Antiretroviral Therapy, Highly Active
  • Prevalence
  • Adult
  • Vietnam
  • Female
  • Male